Introduction
order of magnitude lower than those obtained in rat brain (9.1 and 9.1 respectively), whereas values for doxepin (0.1) and promethazine (1.4) are similar in the two species. These results suggest that there are differences in the structural identity or membrane environment of HI-receptors in the two tissues.
Studies of soluble H ,-receptors isolated from rat and guinea-pig brain provide no physicochemical evidence for the species difference in H Ireceptor properties [9] , although a unique HI-receptor isoform (68 k1)a) has been isolated from guinea-pig atria [ 10 J. This cardiac isoform cannot, however, be distinguished pharmacologically from the isoform present in guinea-pig brain (56 kna) [lo] . It phosphoinositide hydrolysis has also been observed following adenosine A,-receptor stimulation in mouse cerebral cortical slices [18] and GABA, ( yaminobutyric acid)-receptor stimulation in rat cerebral cortex [19] . However, in this case intracellular cyclic AMP does not appear to mediate these inhibitory responses [ZO] . In guinea-pig brain, however, adenosine augments rather than inhibits the inositol phospholipid response to histamine [ZO] . In both cases adenosine has no effect on inositol phospholipid hydrolysis alone [ZO] .
In mammalian brain slices, histamine is a very potent stimulus of cyclic-AMP accumulation and mediates its effect via the activation of both €3?-and HI-receptors [ 71. Stimulation of H2-receptors directly activates adenylate cyclase via the intermediacy of a ( ; , protein, while €I,-receptors act indirectly to augment the cyclic-AMP response to H2-, vasoactive intestinal polypeptide-or adenosine A,-receptor stimulation [21] . This augmentation produced by €1,-receptor activation is not seen in broken-cell preparations and appears to involve the formation and action of inositol 1.45-trisphosphate (leading to intracellular calcium release) and diacylglycerol [ZZ, 231.
Molecular properties of the H,-receptor
Selective labelling of the histamine II,-receptor has proved difficult with the commercially available probes. The properties of the binding sites detected with a range of tritiated I 12-antagonists, including cimetidine and ranitidine, are not ' consistent with those expected of an H,-receptor recognition site [ 1 71. limited success has been reported with the higher-affinity ligand ['I Iltiotidine ( K1 = 15 IN) in brain membranes. but not in peripheral tissues [24] . I lowever, more recently [ '2iI]iodoaminopotentidine ("'I-APT; K,=0.3 nv) has been developed as a highly potent and selective probe for the H2-receptor in guinea-pig brain [2S] . "'I-APT binding in guinea-pig hippocampal and striatal membranes is inhibited by histamine and this interaction can be modulated by guanine nucleotides, which is consistent with the coupling of H2-receptors to a G,-protein [25] . After U.V. irradiation
[ "'I]iodoazidopotentidine ( K , = 10 nil), a photoaffinity probe derived from APT, selectively labelled two bands in guinea-pig hippocampal, striatal and cerebral cortical membranes (59 and 32 kDa on SIXVPAGE analysis) presumably derived from I 1,-receptor-binding peptides [25] . However, it remains a possibility that the 32 klla protein is a proteolytic product of the 59 kDa protein.
The histamine H1-receptor gene has been cloned recently by using synthetic oligonucleotides, complimentary to the DNA encoding the transmembrane region of known G-protein-linked receptors [26] , as primers for the polymerase chain reaction with cDNA from canine-parietal-cell mRNA as a template [27] . The full-length receptor gene encodes a protein containing 359 amino acid residues, the expected seven hydrophobic transmembrane domains of a G-protein-linked receptor and an N-glycosylation concensus sequence at the N-terminus [27] . I, cells transfected with the H2-gene construct showed concentration-dependent increases in intracellular cyclic AMP in response to histamine, which could be antagonized by the H,-receptor antagonist cimetidine ( Kd circa 100 mi).
Transfected I, cells also specifically bound [ 'Hltiotidine, which was displaceable by micromolar concentrations of cimetidine, thus confirming the expression of H,-receptors in these cells [27] .
The amino acid sequence deduced from the H, gene (which appears to be devoid of introns) reveals extensive sequence similarity with other G-protein-linked receptors. In addition the H,-receptor sequence contains an aspartic acid residue in the third transmembrane domain which, from mutational studies of the P-adrenoceptor, appears to be important for binding of the cationic N-group of receptor agonists. I Iowever. the two serine residues which are sites of hydrogen bonding to the hydroxyl groups of catechols in the fifth transmembrane region of the P-adrenoceptor. are absent from the I I?-receptor. These are substituted by aspartic acid and threonine residues which have the ability to interact with the nitrogen moieties on the imidazole ring of histamine [ 271.
Lymphocyte-selective H,-receptor agonists
Histamine H,-receptor stimulation can inhibit a variety of lymphocyte functions including the proliferative response to mitogens, antibody synthesis and cytolysis [l] . Histamine appears to mediate these effects by elevation of intracellular cyclic AMP [28] . An exciting advance in this area of research has been the development of lymphocyte-selective H,-receptor agonists [28, 291 . These have been developed by producing histamine congeners that contain a spacer group of varying length between the histamine moiety and various aromatic groups [28, 301. For example, the trifluoromethyl toluidine derivative of histamine with a four methylene spacer chain is 43000 times more potent than hist- Table I Relative potencies of some methylated histamine derivatives 
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